Noyes Timothy P

CHIEF EXECUTIVE OFFICER, DirectorAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed May 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$231K
Net Open-Market Flow
-$231K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2024Option exercise(M)10K$2.14$21K10K
May 1, 2024Sell(S)9K$20.34$184K965
May 1, 2024Sell(S)965$20.87$20K0
May 1, 2024Sell(S)1K$19.91$27K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2024Option exercise(M)10K$0353K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-012234) within minutes of acceptance. Every field above traces to the original document. Verify it directly: